Ovid Therapeutics (OVID) Other Accumulated Expenses (2016 - 2022)
Ovid Therapeutics (OVID) reported Other Accumulated Expenses of $139167.0 for Q1 2022, down 79.33% on a YoY basis from $673285.0 in Q1 2021, and down 74.53% quarter-over-quarter from $546464.0 in Q4 2021.
Ovid Therapeutics (OVID) Other Accumulated Expenses (2016 - 2022) Analysis & Trends
Ovid Therapeutics has reported Other Accumulated Expenses for 7 years, with the latest figure at $139167.0 in Q1 2022.
- For the quarter ending Q1 2022, Other Accumulated Expenses fell 79.33% year-over-year to $139167.0; the trailing twelve-month figure through Mar 2022 stood at $139167.0 (down 79.33% YoY), and the FY2021 full-year result was $546464.0, up 230.12% from the prior year.
- Other Accumulated Expenses for Q1 2022 stood at $139167.0, down from $546464.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $2.0 million in Q2 2021, with the low at $119940.0 in Q3 2021.
- Historically, Other Accumulated Expenses has averaged $342914.5 across 5 years, with a median of $184923.0 in 2018.
- Annual changes were most pronounced in 2021 — Other Accumulated Expenses soared 621.03% — and 2022, when it plunged 79.33%.
- Ovid Therapeutics' Other Accumulated Expenses stood at $184923.0 in 2018, then grew by 25.51% to $232095.0 in 2019, then decreased by 28.68% to $165536.0 in 2020, then soared by 230.12% to $546464.0 in 2021, then tumbled by 74.53% to $139167.0 in 2022.
- The last three Other Accumulated Expenses figures came in at $139167.0 (Q1 2022), $546464.0 (Q4 2021), and $119940.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ovid Therapeutics | 311.83 Mn | 156.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 139,167.00 |
| Dec 31, 2021 | 546,464.00 |
| Sep 30, 2021 | 119,940.00 |
| Jun 30, 2021 | 1.96 Mn |
| Mar 31, 2021 | 673,285.00 |
| Dec 31, 2020 | 165,536.00 |
| Sep 30, 2020 | 274,903.00 |
| Jun 30, 2020 | 271,314.00 |
| Mar 31, 2020 | 248,813.00 |
| Dec 31, 2019 | 232,095.00 |
| Sep 30, 2019 | 236,716.00 |
| Jun 30, 2019 | 168,798.00 |
| Mar 31, 2019 | 148,414.00 |
| Dec 31, 2018 | 184,923.00 |
| Sep 30, 2018 | 169,347.00 |
| Jun 30, 2018 | 142,796.00 |
| Mar 31, 2018 | 150,768.00 |
| Dec 31, 2017 | 246,503.00 |
| Sep 30, 2017 | 157,015.00 |
| Jun 30, 2017 | 124,320.00 |